申请人:ALIGOS THERAPEUTICS, INC.
公开号:US20220009924A1
公开(公告)日:2022-01-13
Disclosed herein are compounds of Formula I′:
or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising such compounds, and methods of treating disease by administering or contacting a patient with one or more of the above compounds.
本文揭示了以下式I′的化合物:或其立体异构体或互变异构体,或其药学上可接受的盐,包括这些化合物的药物组合物,以及通过向患者施用或接触上述化合物之一或多个来治疗疾病的方法。